NCT01001806 - A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions

Cataracts

Interventions

DRUG

Ketorolac Tromethamine 0.45%

One drop BID the day before surgery and then 3 doses the day of surgery prior to surgery

DRUG

bromfenac 0.09%

One day pre operative 1 drop BID then 3 doses pre op day of surgery

DRUG

nepafenac 0.1%

One drop BID, 1 day pre operative and then 3 doses the day of surgery

Trial Locations (1)

Bucci Laser Vision Institute, Wilkes-Barre